Consolidated Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Income Statement [Abstract]
Revenues	$ 2,039
Operating costs and expenses
General and administrative	23,838	11,683
Research and development	3	830
Research and development - license acquired	(6)	1,833
Total operating expenses	23,835	14,346
Loss from operations	(21,796)	(14,346)
Other income (expenses)
Other income	36	64
Interest income	716	687
Gain (loss) on marketable securities	630	(5,952)
Unrealized loss on note receivable	(3,248)
Change in fair value of investments	780	(2,560)
Total other expenses	(1,086)	(7,761)
Net loss	(22,882)	(22,107)
Deemed dividends related to Series O and Series P Redeemable Convertible Preferred Stock		(4,109)
Net Loss Attributable to Common Shareholders	$ (22,882)	$ (26,216)
Net loss per share, basic and diluted
Net loss per share, basic (in Dollars per share)	$ (4.38)	$ (4.91)
Weighted average number of shares outstanding, basic and diluted
Weighted average number of shares outstanding, basic (in Shares)	5,229,477	5,334,075